Manipal Health Enterprises' Rs 9,275-crore IPO has entered its final day of bidding with investor interest remaining subdued. The issue, backed by Temasek and healthcare entrepreneur Ranjan Pai, has garnered a muted response so far, while the grey market premium (GMP) continues to hover at a modest 1%, leaving investors wondering whether the IPO is worth applying for.
By the end of Day 2, the IPO had received 45% overall subscription against the 9 crore shares on offer. The retail investor quota was also subscribed 45%, with bids placed for 1.64 crore shares reserved for the segment.